Clinical and Molecular Features of KRAS-Mutated Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.
Zhao D, Li H, Mambetsariev I, Mirzapoiazova T, Chen C, Fricke J, Kulkarni P, Villaflor V, Arvanitis L, Hamilton S, Afkhami M, Pillai R, Armstrong B, Erhunmwunsee L, Massarelli E, Sattler M, Amini A, Salgia R.
Zhao D, et al. Among authors: mambetsariev i.
Cancers (Basel). 2022 Oct 8;14(19):4933. doi: 10.3390/cancers14194933.
Cancers (Basel). 2022.
PMID: 36230855
Free PMC article.